Novartis Partners with Generate in $1B Biotech Deal
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
- Latest
- Trending
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
OpenAI and Apple unveil new AI models and iPhone 16. Experts caution about strict U.S. rules and emphasize human oversight.
Bio-Techne shows resilience with strategic growth in diagnostics despite fiscal year challenges and market declines.
Cathie Wood's ARK shifts focus, selling Ginkgo and Coinbase, while investing in 10X Genomics and Roku in a biotech-centered portfolio ...
"NASA STAR program open for applications until June 28. Join elite researchers in space biology training and experiment opportunities in ...
E3technology enhances Empore™ membranes for better proteome sample prep, crucial for low-cell proteomics, say experts at UD and CDS Analytical.
The Open Medical-LLM leaderboard offers valuable insights into AI-related medical devices, although none of the approved devices use generative AI.
Meta has released a new version of its Llama AI model to compete with OpenAI, X, and Google. Despite ongoing ...
Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
Anthropic believes in building safe AI models to ensure an ethical AI future. The company focuses on developing safe AI ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.